Pharmaceutical companies

Pharmaceutical companies developing or marketing new drugs for ATTR amyloidosis:

Alnylam:

Ionis

Pfizer – tafamidis

GSK (in association with the Wolfson Drug Discovery Unit)miridesap + dezamizumab